Brief: Genxone Signs Up To EUR 195,500 Deal With gMendel
July 20 (Reuters) - Genxone SA GX1.WA :
* SIGNS DEAL WITH GMENDEL
* DEAL VALUE UP TO EUR 195,500
* DEAL FOR DEVELOPMENT AND GLOBAL MARKET INTRODUCTION OF
TOOL
BASED ON NANOPORE TECHNOLOGY AND PHIVEA PLATFORM, USED FOR
DIAGNOSTICS OF 3 RARE GENETIC DISEASES
Source text for Eikon: ID:nEM16BVLna
Further company coverage: GX1.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Genxone SA
See all newsBrief: Genxone Q2 Net Loss 0.3 Million Zlotys
Brief: Genxone 1.2 Mln Zloty Offer For NGS Sequencing Services Chosen As Most Favourable In Tender
Brief: Genxone Signs 93,990 Zloty Contract With Medical University Of Warsaw For Gut Microbiota DNA Sequencing Services
Brief: Genxone Q1 Net Loss 0.5 Million Zlotys
Brief: Genxone FY Net Loss 2.6 Million Zlotys